Retatrutide: difference between revisions
Diff·revision 7 → 8·00:18, 29 Aug 2024
Difference between revision 7 and revision 8 of Retatrutide. 4 lines changed; the page grew by 106 bytes.
| Revision 7 — 18:08, 19 Aug 2024 GMP_Gita (talk) add CAS number, sourced 3,206 bytes +484 | Revision 8 — 00:18, 29 Aug 2024 IncretinIvo (talk) attribute the mechanism claim to the review rather than stating it flatly 3,312 bytes +106 | ||
|---|---|---|---|
| 5 | | Class = Triple agonist (GIP/GLP-1/glucagon) | 5 | | Class = Triple agonist (GIP/GLP-1/glucagon) |
| 6 | | Status = Phase 3; not approved | 6 | | Status = Phase 3; not approved |
| + | 7 | <!-- Identifiers --> | |
| + | 8 | | CAS Number = 2381089-83-2 | |
| + | 9 | | Residues = 39 | |
| + | 10 | | Molar mass = ≈4,731 g·mol⁻¹ | |
| 7 | }} | 11 | }} |
| 8 | 12 |